15 December 2022, London – Qinecsa Solutions UK Ltd. (Qinecsa) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth). Qinecsa, a leading provider of pharmacovigilance services and technologies to the global pharmaceutical industry.
Headquartered in Massachusetts, USA, Commonwealth, an independently-operated subsidiary of Genpact, is the technology leader in signal management, providing an innovative cloud-based solution that leverages advanced analytics to help clients improve drug safety through end-to-end signal detection and risk management. The firm’s clients include large and medium-sized life science companies, government regulatory agencies, and public health organizations across the US, UK, Europe, and Asia.
The acquisition of Commonwealth provides a significant step for Qinecsa and its clients, toward creating an end-to-end vigilance platform in the market. The combination brings together world-class pharmacovigilance services with a proven and scalable platform for the digital capture, processing, analysis, and reporting of safety data. This transaction also marks Qinecsa’s second acquisition of 2022, following the acquisition of Reportum in April. Reportum is an innovative case intake and digital workflow platform for pharmacovigilance, serving some of the largest businesses across the global pharmaceutical industry.
“We are excited to be adding the Commonwealth Vigilance Workbench to Qinecsa’s portfolio of solutions. We believe the combination of Qinecsa’s scientific expertise in pharmacovigilance, SCP’s strategic support, and Commonwealth’s agile innovation will allow us to significantly strengthen the value we deliver to clients. We look forward continuing our work to improve the safe and effective use of healthcare products worldwide.”
“The Qinecsa team is very pleased to be welcoming Commonwealth to the organisation. We are excited to work together to integrate leading signal detection software into Qinecsa’s solutions. Our clients, existing and future, will further benefit from the development of our analytical and consultancy services.”
About Qinecsa Solutions UK
Qinecsa is a trusted partner to global life science companies. We bring together best-in-class technology and scientific expertise to connect life science companies to the right safety solutions. Through our unique insight into the challenges of pharmacovigilance, we have created industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately. Working with life science companies we drive progress to continue protecting lives.
About Commonwealth Informatics, Inc.
Commonwealth Informatics, an independently-operated subsidiary of Genpact, is a technology and services company with industry expertise in medical product safety and public health surveillance. Pharmaceutical and biotechnology companies, government agencies, and healthcare providers use Commonwealth’s products and services to assemble relevant data and answer complex clinical and safety analysis questions quickly and accurately.
